A61K 47/543
Lipids
Official title: {Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine}
A61K47/543 (Lipids) appears on 1,158 US grants and 1,860 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,158
- Published applications
- 1,860
- Assignees
- 762
- Inventors
- 3,212
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 4 | 0 |
| 1992 | 9 | 0 |
| 1993 | 5 | 0 |
| 1994 | 8 | 0 |
| 1995 | 8 | 0 |
| 1996 | 9 | 0 |
| 1997 | 10 | 0 |
| 1998 | 32 | 0 |
| 1999 | 28 | 0 |
| 2000 | 32 | 0 |
| 2001 | 18 | 4 |
| 2002 | 27 | 28 |
| 2003 | 18 | 32 |
| 2004 | 11 | 41 |
| 2005 | 12 | 53 |
| 2006 | 24 | 45 |
| 2007 | 12 | 26 |
| 2008 | 13 | 39 |
| 2009 | 19 | 39 |
| 2010 | 19 | 56 |
| 2011 | 25 | 44 |
| 2012 | 24 | 60 |
| 2013 | 20 | 65 |
| 2014 | 39 | 92 |
| 2015 | 76 | 96 |
| 2016 | 80 | 114 |
| 2017 | 57 | 84 |
| 2018 | 88 | 69 |
| 2019 | 54 | 88 |
| 2020 | 43 | 91 |
| 2021 | 59 | 105 |
| 2022 | 46 | 103 |
| 2023 | 58 | 109 |
| 2024 | 59 | 170 |
| 2025 | 61 | 123 |
| 2026 | 34 | 84 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Pharmaceutical composition containing anionic drug, and preparation method therefor6 Oct 2026US 12,752,010 B2Samyang Holdings Corporation
- Ionizable cationic lipid analog material and use thereof as drug delivery carrier29 Sep 2026US 12,746,288 B2Guangzhou Lide Biomedicine Technology Co., Ltd.
- Methods of loading extracellular vesicles29 Sep 2026US 12,746,291 B2Lonza Sales AG
- Ionizable cationic lipids for RNA delivery1 Sep 2026US 12,723,023 B2Arcturus Therapeutics, Inc.
- Liposomal formulations comprising AT1 receptor blockers and uses thereof25 Aug 2026US 12,714,669 B2Yissum Research Development Company of the Hebrew University of Jerusalem
- Microbiome-based GABA Cream with Chondroitin Sulfate Transdermal Delivery System8 Oct 2026US 2026/0306531 A1
- Biologically compatible, biofilm disrupting composition and methods1 Oct 2026US 2026/0294861 A1
- Photoactivatable nanoparticles and uses thereof as agents for immunotherapy combinations1 Oct 2026US 2026/0295050 A1Board of Regents, The University of Texas System
- Artificial amino acid containing lipo-oligomers for ribonucleoprotein delivery1 Oct 2026US 2026/0295075 A1Ludwig-Maximilians-Universitat Munchen
- Ceramide-like lipid-based delivery vehicles and uses thereof17 Sep 2026US 2026/0273065 A1Children's Medical Center Corporation
Most cited
By later US patents
- Cationic lipids for intracellular delivery of biologically active molecules586US 5,459,127 AVical Incorporated · 1995
- Cationic lipids for intracellular delivery of biologically active molecules545US 5,264,618 AVical Incorporated · 1993
- Charged lipids and uses for the same361US 6,120,751 AImaRx Pharmaceutical Corp. · 2000
- Cationic lipids334US 5,334,761 ALife Technologies Corporation · 1994
- Lipopolyamines, their preparation and their use287US 5,171,678 ACentre National De La Recherche Scientifique · 1992